NEW YORK, Nov. 16 - Celera Genomics’ acquisition of Axys Pharmaceuticals was formally approved by the US Securities and Exchange on Friday, Celera said. The transaction will be put to bed at the close of business in California on Friday and from then on Axys will do business under the Celera name.


To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers in China have generated mouse pups from same-sex parents, according to Scientific American.

Two research teams find a role for PIEZO2 in touch sensitivity after injury and inflammation.

The South China Morning Post reports that Hong Kong plans to add HK$20 billion (US$2.6 billion) to a research endowment.

In Science this week: open genetic genealogy databases can lead to the identification of individuals who have not sought testing, and more.